Please Wait
Applying Filters...
menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-24

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Nirmatrelvir

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 11,187Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3Paxlovid

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Paxlovid

    Nirmatrelvir

    arrow
    ELCC
    Not Confirmed

    Brand Name : Paxlovid

    U.S.A
    arrow
    ELCC
    Not Confirmed

    Pfizer Inc.

    Nirmatrelvir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2021 Revenue in Millions : 76

    2020 Revenue in Millions : 0

    Growth (%) : New Launch in 2021

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Paxlovid

    Nirmatrelvir

    arrow
    ELCC
    Not Confirmed

    Brand Name : Paxlovid

    U.S.A
    arrow
    ELCC
    Not Confirmed

    Pfizer Inc.

    Nirmatrelvir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2022 Revenue in Millions : 18,933

    2021 Revenue in Millions : 76

    Growth (%) : 24,812

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Paxlovid

    Nirmatrelvir

    arrow
    ELCC
    Not Confirmed

    Brand Name : Paxlovid

    U.S.A
    arrow
    ELCC
    Not Confirmed

    Pfizer Inc.

    Nirmatrelvir

    Main Therapeutic Indication : Infectious Diseases

    Currency : USD

    2023 Revenue in Millions : 1,279

    2022 Revenue in Millions : 18,933

    Growth (%) : -93

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF